Distinguishing myelofibrosis from polycythemia vera and essential thrombocythemia: The utility of enumerating circulating stem cells with aberrant hMICL expression by flow cytometry
ConclusionEnumeration of circulating hMICL+ stem cells by FCM can discriminate between MPN phenotypes and holds potential for monitoring disease evolution.
Source: Clinical and Laboratory Haematology - Category: Hematology Authors: L. L. Herborg, L. Nederby, H. C. Hasselbalch, A. Aggerholm, A. S. Roug Tags: ORIGINAL ARTICLE Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Laboratory Medicine | Leukemia | Myeloproliferative Disorders | Stem Cell Therapy | Stem Cells